Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1989;74:259-261
© 1989 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christian, S. S.
Right arrow Articles by Duff, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christian, S. S.
Right arrow Articles by Duff, P.

Is universal screening for hepatitis B infection warranted in all prenatal populations?

Stefanie Schupp Christian, MD and Patrick Duff, MD

From the Division of Maternal-Fetal Medicine, Madigan Army Medical Center, Tacoma, Washington

The purpose of this prospective study was to determine the prevalence of asymptomatic hepatitis B infection in a low-risk, closely monitored population. At the time of their first prenatal evaluation, a cohort of active-duty military personnel and their dependents underwent screening for hepatitis B surface antigen. Ten of 1520 women (0.66%) tested positive. All of these women were Asians and would have been identified under a selective screening protocol. None of the ten seropositive patients had other risk factors for hepatitis B infection. We conclude that in this type of population, universal screening for hepatitis B is not cost-effective. Selective screening for high-risk patients would appear to be more appropriate.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American College of Obstetricians and Gynecologists.